Skip to main content
Theodore Nowicki, MD, Pediatric Hematology & Oncology, Los Angeles, CA, Mattel Childrens Hospital University of California Los Angeles

TheodoreScottNowickiMD

Pediatric Hematology & Oncology Los Angeles, CA

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Physician

Dr. Nowicki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nowicki's full profile

Already have an account?

  • Office

    10833 Le Conte Avenue
    Room A2-410 MDCC
    Los Angeles, CA 90095
    Phone+1 310-825-6708
    Fax+1 310-825-6708
  • Is this information wrong?

Summary

  • Dr. Theodore Nowicki is a pediatric hematologist/oncologist in Los Angeles, CA and is affiliated with Ronald Reagan UCLA Medical Center. He received his medical degree from New York Medical College and has been in practice 4 years. He specializes in pediatric sarcoma oncology and pediatric solid tumor oncology.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 2016 - 2019
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 2013 - 2016
  • New York Medical College
    New York Medical CollegeClass of 2013

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2024
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-cell Populations  
    Zeynep Eroglu, Iman Osman, Theodore S Nowicki, Antoni Ribas, Michael A Davies, Farbod Darvishian, Daniel Y Wang, Douglas B Johnson, Ravi K Amaravadi, Clinical Cancer Research

Press Mentions

  • Low Blood Phosphate Levels May Be Linked to Neurological Side Effects from CAR T-cell Therapy
    Low Blood Phosphate Levels May Be Linked to Neurological Side Effects from CAR T-cell TherapyOctober 19th, 2022
  • $4.6M CIRM Grant to Fund Phase 1 Trial of New Immunotherapy for Advanced Sarcoma, Difficult-to-Treat Cancers
    $4.6M CIRM Grant to Fund Phase 1 Trial of New Immunotherapy for Advanced Sarcoma, Difficult-to-Treat CancersMay 14th, 2019
  • $4.6 Million Grant Funds Clinical Trial of Stem Cell Immunotherapy for Metastatic Sarcoma and Other Hard-to-Treat Cancers
    $4.6 Million Grant Funds Clinical Trial of Stem Cell Immunotherapy for Metastatic Sarcoma and Other Hard-to-Treat CancersApril 30th, 2019

Hospital Affiliations